-+ 0.00%
-+ 0.00%
-+ 0.00%

*Cybin: 12-Mo Efficacy Data From Phase 2 CYB003 MDD Study Expected in 4Q >CYBN

Dow Jones·11/13/2024 12:36:00

Please log in to view news